Your browser doesn't support javascript.
loading
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer.
Reuss, Joshua E; Anagnostou, Valsamo; Cottrell, Tricia R; Smith, Kellie N; Verde, Franco; Zahurak, Marianna; Lanis, Mara; Murray, Joseph C; Chan, Hok Yee; McCarthy, Caroline; Wang, Daphne; White, James R; Yang, Stephen; Battafarano, Richard; Broderick, Stephen; Bush, Errol; Brock, Malcolm; Ha, Jinny; Jones, David; Merghoub, Taha; Taube, Janis; Velculescu, Victor E; Rosner, Gary; Illei, Peter; Pardoll, Drew M; Topalian, Suzanne; Naidoo, Jarushka; Levy, Ben; Hellmann, Matthew; Brahmer, Julie R; Chaft, Jamie E; Forde, Patrick M.
Afiliação
  • Reuss JE; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Anagnostou V; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • Cottrell TR; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Smith KN; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • Verde F; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Zahurak M; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • Lanis M; Department of Radiology, Johns Hopkins, Baltimore, Maryland, USA.
  • Murray JC; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Chan HY; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • McCarthy C; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Wang D; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • White JR; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, USA.
  • Yang S; Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Battafarano R; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Broderick S; Department of Pathology, Johns Hopkins, Baltimore, Maryland, USA.
  • Bush E; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Brock M; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Ha J; Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Jones D; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Merghoub T; Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Taube J; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Velculescu VE; Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Rosner G; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Illei P; Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Pardoll DM; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Topalian S; Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Naidoo J; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, Maryland, USA.
  • Levy B; Department of Surgery, Johns Hopkins, Baltimore, Maryland, USA.
  • Hellmann M; Thoracic Surgery Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Brahmer JR; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Chaft JE; Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Forde PM; Weill Cornell Medical College, New York, New York, USA.
J Immunother Cancer ; 8(2)2020 09.
Article em En | MEDLINE | ID: mdl-32929052
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Terapia Neoadjuvante / Ipilimumab / Nivolumabe / Neoplasias Pulmonares Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Terapia Neoadjuvante / Ipilimumab / Nivolumabe / Neoplasias Pulmonares Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido